The intervention using anti-Lair1 antibody resulted in multiple actions, including repolarization of M2-like MΦ to M1 MΦ for an antitumor effect, enhancement of tumor–T cell interaction for cytolytic killing, and reduction of tumor-associated collagen deposition to normalize the TME. The gene discussed is LAIR1; the disease is neoplasm.